Vexas syndrome: a new hematoinflammatory disease

Authors

DOI:

https://doi.org/10.5281/zenodo.8104842

Keywords:

hematology, Vexas syndrome, hematoinflammatory disease

Abstract

Reference is made to a new autoinflammatory condition of acquired etiology, named VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic). This syndrome is due to mutations of the ubiquitin enzyme 1 (UBA1) and is most commonly diagnosed in men older than 50 years. Medical personnel of aging populations are alerted, in particular, Cuba.

Downloads

Download data is not yet available.

References

Al-Hakim A, Savic S. An update on VEXAS syndrome. Exp Rev Clin Immunol [Internet]. 2023 Feb [citado 7 Feb 2023]; 19(2):203-215. Doi: https://doi.org/10.1080/1744666X.2023.2157262

Georgin-Lavaialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lázaro E, et al. Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients. Br J Dermatol [Internet]. 2022 Mar [citado 7 Feb 2023]; 186(3):564-574. DOI: https://doi.org/10.1111/bjd.20805

Downloads

Published

2023-07-04

How to Cite

1.
Blanco-Alvarez RM, Carbonell-Labadie SH, Montes de Oca-Carmenaty M. Vexas syndrome: a new hematoinflammatory disease. Rev Inf Cient [Internet]. 2023 Jul. 4 [cited 2025 May 9];102:4264. Available from: https://revinfcientifica.sld.cu/index.php/ric/article/view/4264

Issue

Vol. 102 (2023)

Section

Letter to Editor

License

Copyright (c) 2023 Roberto Michael Blanco-Alvarez, Sonia Haila Carbonell-Labadie, Margarita Montes de Oca-Carmenaty

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.